Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

GSK investigator jailed by Chinese authorities

Peter Humphrey found guilty of breaking privacy laws

- PMLiVE

FDA approves J&J’s diabetes combo

Invokamet combines Invokana and metformin to help reduce blood sugar

- PMLiVE

Sanofi cuts $925m deal for MannKind’s inhaled insulin

French company bolsters diabetes business with Afrezza collaboration

- PMLiVE

Dancing with the Deval

Allowing states to circumvent FDA drug approvals would set a dangerous precedent

EU flag

International regulators collaborate on generics

EMA leads three-year pilot project to increase pre-market data sharing

- PMLiVE

Wendy Wolf joins Ashfield Healthcare

Takes up role as senior vice president of commercial and clinical operations

- PMLiVE

Pfizer closes on $1bn label expansion for Prevenar

EMA begins review of the pneumococcal vaccine

- PMLiVE

Baxter opens Advate facility in Singapore

Follows EU approval for haemophilia A drug plant

MS market set to grow 4% annually

Predictedto reach $20bn by 2023 partly due to Plegridy and ocrelizumab launches

- PMLiVE

Roche blasts UK’s ‘broken’ HTA system as Kadcyla rejected

But NICE says it is 'very disappointed' with the company's pricing policy

- PMLiVE

emotive continues to grow

London digital agency appoints Aaron Joshua Barroso digital marketing manager

- PMLiVE

Has the biological revolution in rheumatoid arthritis peaked?

In the short term the focus looks set to be on personalised use of existing therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links